Stay updated on APR-246+Azacitidine Post-AlloSCT in TP53 Mut AML/MDS Clinical Trial
Sign up to get notified when there's something new on the APR-246+Azacitidine Post-AlloSCT in TP53 Mut AML/MDS Clinical Trial page.

Latest updates to the APR-246+Azacitidine Post-AlloSCT in TP53 Mut AML/MDS Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision v3.5.0 was added to the history and v3.4.3 was removed.SummaryDifference0.1%

- Check26 days agoChange DetectedAdded revision v3.4.3 and removed revision v3.4.2 from the record history.SummaryDifference0.1%

- Check54 days agoChange DetectedA new revision entry (v3.4.2) was added to the history, and older notices about funding and the previous revision (v3.4.1) were removed.SummaryDifference0.7%

- Check62 days agoChange DetectedRecord History shows a new site-wide notice about government funding and an updated Revision: v3.4.1, with the previous Revision: v3.4.0 removed. These maintenance updates do not affect trial content, data, or user-facing study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check69 days agoChange DetectedUI improvements include a glossary toggle and color-coded change highlights (green for additions, red for deletions) with a legend, and explicit revision notes (e.g., v3.4.0) on the history page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1.0%

- Check83 days agoChange DetectedNew revision entry v3.3.4 was added to the study record history, and v3.3.3 was removed; this is a minor metadata update to the history log and does not alter the study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to APR-246+Azacitidine Post-AlloSCT in TP53 Mut AML/MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APR-246+Azacitidine Post-AlloSCT in TP53 Mut AML/MDS Clinical Trial page.